Request for Proposals
The Cure JM Foundation (Cure JM) announces its Request for Proposals for 2017 for advancing research to improve medical treatment, patient care, and work toward a cure for Juvenile Myositis. Grants are made in collaboration with the Childhood Arthritis and Rheumatology Research Alliance (CARRA).
Cure JM is a 501(c)(3) non-profit organization established in 2003. The mission of Cure JM is to find better treatments and a cure for Juvenile Myositis, and improve the lives of families affected by JM. Approximately 2 to 4 children in a million in the United States are diagnosed with JM each year.
CARRA’s mission is to conduct collaborative research to prevent, treat and cure pediatric rheumatic diseases. Its approach is that CARRA members will work together to capitalize on opportunities, actively develop a structure and a scientific agenda, and collaborate with potential funding sources to create a research alliance that benefits our patients. For more information, visit the CARRA website at carragroup.org.
In 2017, Cure JM has committed to fund 2-4 new research grants up to $75K/year for up to 2 years with preference for individuals who have at least 25% protected research time from their institution.
Grant Application Process
An electronic letter of intent (LOI) submission form is required 30 days before the deadline for full application and must contain the project title, a brief description of the proposed research, the name, address and email address of the Principal Investigator(s), and any persons who might have a conflict of interest in reviewing the proposal. The LOI must be submitted electronically via this online form. The LOI is only to allow organization of the review process, and all projects submitting an LOI will be permitted to submit a full application.
Proposals should be submitted electronically as one single PDF format file via this online submission form and must be received by the submission deadline for applications stated in the research announcement timeline. (See Grant Application for specific information.)
|Request for Proposals Begins||March 31, 2017|
|Letter of Intent Deadline||May 15, 2017|
|Application Deadline||June 15, 2017|
|Review of Submitted Applications Completed||September, 2017|
|Anticipated Date for Notification of Awards||October, 2017|
|Anticipated Funding Start Date||November 1, 2017|
The proposal is up to 4 pages long, and the following are also required but do not count toward page limits:
- A lay summary no longer than one page written at the 8th grade reading level
- A curriculum vitae/biosketch in NIH format
- A letter of support is required either from either a division head/department chair/supervisor at your institution.
- A letter of collaboration submitted by each and all investigators involved in the grant proposal
- If samples (blood, muscle, skin, etc.) are to be studied and they were not obtained with an IRB approved informed consent by the PI, then a letter of collaboration is needed from the investigator who did obtain those samples, citing the IRB #.
Applicants must hold a Ph.D. or M.D. degree or equivalent and work in an accredited medical school, university, hospital or research institute which must agree to supply the clinical and/or laboratory facilities.Cure JM strongly encourages junior researchers and researchers without pediatric rheumatology experience to work with established JM researchers. All basic, clinical and /or translational research proposals related to the field of juvenile myositis will be considered.
Research proposals are reviewed by selected members of CARRA or other experts in the field utilizing the NIH Grant Application Scoring System. The proposal scores along with feedback from the reviewers will be shared with the Cure JM Research Committee for evaluation. The Research committee will make recommendations for funding to the Cure JM Board for a final funding decision. Applicants will be notified by the Cure JM Director for Research when a decision is made.
Reports and Payments
Annual progress reports are required to be submitted by the Principal Investigator and shall be due no later than 30 days after the close of the grant’s first year. A Final Report including a full financial report and progress report is required within 60 days after the end of the grant period. Both annual and final reports are required to include an expenditure report detailing how the award has been spent. A layperson summary (200-300 words) of major accomplishments and relevance to JM patients shall accompany each Progress report and the final report. Award payments will be made at the beginning of the project year and at 12 months, pending receipt of the annual progress report.
A detailed budget should provide itemized detail for each major category of the budget report included in the application. The award does not provide for indirect costs. Award funding may be used for salary support, consumable supplies, equipment, travel (< $1500) and other items necessary to conduct the proposed research.
All Cure JM funded proposals must contain a lay person abstract for Cure JM’s use in press releases. Cure JM Foundation must be acknowledged in all dissemination materials (e.g. publications, scientific exhibit, scientific presentation, press release, etc.) related to research supported in full or in part using this grant and one copy of any published reports must be sent to Cure JM within 30 days of final production.
Manuscripts resulting from the award must adhere to the CARRA publication policy guidelines and must acknowledge Cure JM and CARRA in all dissemination materials. A stipulation of award acceptance would be travel to the Cure JM medical conference and Cure JM annual family conference/recognition dinner following receipt of the award.